June 2022 Legislative & Regulatory Briefing; ICYMI: Come (Learn) PIE with Me eLearning Days Webinar; AMCP Joins Pharmacy Stakeholders Advocating for PHEPharmacy Staffing Flexibility; [Blog] Why PIE and the Prescription Digital TherapeuticsAct Matter: Recap of AMCP Legislative Days.
May 2022 Legislative & Regulatory Briefing; ICYMI: AMCP Policy & Government Relations Agenda Webinar; AMCP Officially Named Healthy People 2030 Champion; ICYMI: Come (Learn) PIE with Me eLearning Days Webinar.
March 2022 Legislative & Regulatory Briefing; AMCP Legislative Agenda 2022 and Beyond Webinar –Thursday, April 7; AMCP Signals Support for Legislative Priorities; AMCP Supports Authorization for Pharmacists to OrderCOVID-19 Antivirals; AMCP Responds to Part D Proposed Rule; AMCP is a Healthy People 2030 Champion.
Register for the 2022 Policy Outlook Webinar Today; Ask Congress to Support Cures 2.0; AMCP Releases State Model Legislation; CMS Actions on Alzheimer’s Drugs and 2023 Part D Rule; Request for Medicare Payment Advisory Commission(MedPAC) Nominations.
AMCP Publishes New Pay-for-Performance Principles; AMCP Joins Public Health Leaders in Defense of OSHA’s COVID-19 Vaccine Rule; AMCP Supports Dr. Robert Califf’s Nomination for FDA Commissioner; ICYMI: AMCP Quarterly Legislative and Regulatory Briefing Now Available; Reps. DeGette and Upton Release the Cures 2.0 Act; AMCP Seeking New Regulatory Affairs Director.
